December 16, 2019
CB2 Partners with GL Brands in CBD Trial
CB2 Insights Announces Industry’s First Full-Scale Hemp-based Cannabidiol (CBD) Prospective Trial in Partnership with GL…
December 11, 2019
CB2 Insights Launches Warrant Incentive Program
TORONTO, Dec. 11, 2019 (GLOBE NEWSWIRE) — CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”),…
December 3, 2019
CB2 Announces Collaboration with FCM Global
CB2 Insights Announces Collaboration with FCM Global to Support Medical Cannabis R&D in Colombia TORONTO,…
November 14, 2019
CB2 to Participate at Piper Jaffray’s Healthcare Conference
TORONTO, ON – November 14, 2019 – CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a leading…
November 8, 2019
CB2 Insights Announces Record Revenue of $4.2 million
CB2 Insights Announces Record Revenue of $4.2 million for the Third Quarter 2019; Sequential Growth…
October 31, 2019
CB2 Announces Preliminary Unaudited Q3 2019 Revenue of $4.2M
CB2 Insights Announces Record Preliminary Unaudited Q3 2019 Revenue of $4.2 Million and Details for…
October 29, 2019
VIVO and CB2 Insights Enter Technology and Research Partnership
Partnership to focus on implementing a medical product development strategy for VIVO’s global medical cannabis…
September 19, 2019
CB2 Licenses EDC Software to MyAccess Clinics In the UK
CB2 Insights Licenses Electronic Data Capture Software to MyAccess Clinics for Use In the UK…
